Table 2 Showed the mean and 95% confidence interval for each objective prescription calculated for each scenario and the subjective prescription.

From: Clinical and simulated impact of intraocular lens tilt and decentration based on real-world data and optical simulation

  

Aligned

Decentration

Tilt

Decentration + Tilt

MinRMS

M (D)

0.59 (0.52, 0.67)

0.55 (0.47, 0.62)

0.44 (0.36, 0.52)

0.40 (0.32, 0.48)

J0 (DC)

-0.05 (-0.11, 0.01)

-0.06 (-0.11, 0.00)

-0.11 (-0.17, -0.05)

-0.11 (-0.17, -0.05)

J45 (DC)

0.09 (0.05, 0.13)

0.09 (0.05, 0.13)

0.06 (0.02, 0.10)

0.08 (0.03, 0.12)

Paraxial

M (D)

0.29 (0.22, 0.37)

0.24 (0.17, 0.32)

0.14 (0.07, 0.22)

0.09 (0.01, 0.17)

J0 (DC)

-0.06 (-0.11, -0.00)

-0.06 (-0.12, -0.01)

-0.11 (-0.17, -0.06)

-0.12 (-0.18, -0.06)

J45 (DC)

0.09 (0.05, 0.13)

0.09 (0.05, 0.13)

0.05 (0.01, 0.10)

0.07 (0.03, 0.11)

Optimized VSX

M (D)

0.55 (0.47, 0.62)

0.46 (0.38, 0.54)

0.29 (0.20, 0.37)

0.21 (0.12, 0.29)

J0 (DC)

-0.06 (-0.11, -0.01)

-0.07 (-0.12, -0.01)

-0.08 (-0.14, -0.03)

-0.10 (-0.16, -0.04)

J45 (DC)

0.09 (0.05, 0.13)

0.09 (0.05, 0.13)

0.08 (0.04, 0.12)

0.11 (0.07, 0.15)